About the Generic Medicines Group

The Generic Medicines Group is a sector group of Medicines for Europe, representing the generic medicines developers and manufacturers, which provide high-quality cost-competitive medicines to millions of patients in Europe and around the world. Over 350 manufacturing and research & development sites across Europe produce your essential medicines, employ over 160.000 employees and invest 7-17% of their turnover into R&D activities. Generic medicines account today for 56% of all dispensed medicines but for only 22% of the pharmaceutical expenditure in Europe. In other words, generic medicines only account for 4% of total healthcare costs. Without generic medicines, Europe would have had to pay €100 billion more in 2014 to get the same level of access to treatment as we have today. The European generic medicines industry vision is to provide sustainable access to high quality medicines for all patients, based on 5 important pillars: patients, quality, value, sustainability and partnership. For more information please follow us at www.medicinesforeurope.com and on Twitter @genericsEU.

Mission and Vision

MISSION: To provide access to high-quality cost-competitive medicines to European patients.

VISION: Through partnership with key EU stakeholders, the generic medicines industry aims to increase access to medicines without increasing the overall treatment cost.

Structure

generics_structure

Members

I. Member Companies

Alfred E. Tiefenbacher
View website;
ALKALOID
View website;
Allergan
View website;
Apotex Europe
View website;
Cinfa Biotech
View website;
Consilient Health Ltd
View website;
FARMOZ
View website;
FRESENIUS KABI
View website;
Gedeon Richter Ltd
View website;
JGL
;
medichem
View website;
MEDOCHEMIE
View website;
Polpharma
View website;
SANDOZ
View website;
SANOFI
View website;
Sopharma Pharmaceuticals
View website;
Synthon
View website;

II. Affiliate Members

Anapharm Europe
View website;
Billev Pharma
View website;
Billev Pharma East
View website;
DISPHAR INTERNATIONAL
View website;
Farmaprojects
View website;
Glenmark
View website;
HETERO
View website;
JSC Farmak
View website;
PharOS
View website;

III. National Associations – Full Members

AESEG (ES)
View website;
APOGEN (PT)
View website;
AssoGenerici (IT)
View website;
BGMA (UK)
View website;
BOGIN (NL)
View website;
FeBelGen (BE)
View website;
GEMME (FR)
View website;
IEIS (TR)
View website;
IGL (DK)
View website;
ProGenerika (DE)
View website;
PZPPF (PL)
View website;

IV. National Associations – Affiliate Members

APMGR (RO)
View website;
BGPharmA (BG)
View website;
CAFF (CZ)
View website;
FGL (SE)
View website;
GE (HU)
View website;
GENAS (SK)
View website;
HEA (IE)
;
OEGV (AT)
View website;

Become a Member

Medicines for Europe is the official trade association for the European generic, biosimilar and value-added pharmaceutical industries, representing, supporting and developing our common scientific and technical interests within the European Union, Europe as a whole as well as between the European Union and third countries

Why become a member

Medicines for Europe provides many benefits to its members. We represent the voice of our members at European level on all matters affecting our industries.

  • Be part of a strong and united association
  • Benefit from joint expertise and access to information
  • Play your part in the sustainability and competitiveness of our industries
  • Be fully informed on market access, regulatory and legal issues affecting us all
  • Enhance your influence at European level
  • Network with your peers
  • Attend our many conferences and events at reduced member rates

For more information on how to become a member of Medicines for Europe, please click here.